Orion Oyj : Listing prospectus for Orion Corporation's EUR 150 million bond
ORION CORPORATION STOCK EXCHANGE RELEASE11 JUNE 2013 at 2.00 p.m.EEST
On 4 June 2013, Orion Corporation announced that it had resolved to issue a
EUR 150 million fixed rate unsecured bond with a maturity of six (6) years.
The Finnish Financial Supervisory Authority has approved the listing
prospectus of the bond today. The prospectus is available on Orion
Corporation's website http://www.orion.fi/en/investors.
The Company has submitted an application to NASDAQ OMX Helsinki Ltd to apply
for the listing of the bond. The bond is expected to be admitted to public
trading on or about 12 June 2013.
Timo Lappalainen Jari Karlson
President and CEO CFO
Orionintie 1A, FI-02200 Espoo, Finland
Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical
ingredients and diagnostic tests. The company is continuously developing new
drugs and treatment methods. Pharmaceutical R&D focuses on central nervous
system drugs, oncology and critical care drugs, and Easyhaler® pulmonary
Orion's net sales in 2012 amounted to EUR 980 million and the company had
about 3,500 employees. Orion's A and B shares are listed on NASDAQ OMX
The information contained in this release shall not constitute an offer to
sell securities of Orion Corporation in any jurisdiction. In particular, this
release does not constitute an offer to sell securities in the United States.
Any securities referred to herein have not been, and will not be, registered
under the U.S. Securities Act of 1933, as amended, and may not be offered,
exercised or sold in the United States absent registration or an applicable
exemption from registration requirements.
This announcement is distributed by Thomson Reuters on behalf of Thomson
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.
Source: Orion Oyj via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.